Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Pernod

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Journal of Vascular Surgery. Venous and Lymphatic Disorders|August 19, 2017
Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluationSophie Blaise, Bernadette Satger, Gilles Pernod, et al.
Thrombosis Research|March 4, 2014
Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trialPatrick Imbert, Gilles Pernod, Jean-Pierre Jacquet, et al.
Family Practice|October 24, 2024
Patients treated with vitamin K oral anticoagulants in family practice: a new approach to bleeding risk assessment. An ancillary study by the CACAO prospective general practice cohortYoann Gaboreau, Paul Frappé, Celine Vermorel, et al.
Journal of Thrombosis and Thrombolysis|April 25, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism: commentYoann Gaboreau, Nora Zenatti, Céline Vermorel, et al.
Family Practice|January 28, 2024
Oral anticoagulant safety in family practice: prognostic accuracy of Bleeding Risk Scores (from the CACAO study)Yoann Gaboreau, Paul Frappé, Céline Vermorel, et al.
Thrombosis Research|January 23, 2017
Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohortNora Zenati, Yoann Gaboreau, Cynthia Brousseau Provencher, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 31, 2004
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four casesPatricia Pavese, Agnès Bonadona, Jean Beaubien, et al.
Thrombosis and Haemostasis|April 8, 2006
Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Description of 62 novel mutationsChristine Vinciguerra, Christophe Zawadzki, Yesim Dargaud, et al.
European Journal of Radiology|April 21, 2010
Non-severe pulmonary embolism: prognostic CT findingsAnne-Line Moroni, Jean-Luc Bosson, Noélie Hohn, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|September 24, 2015
[Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management]Claire Soave, Elena Chidlovskii, Audrey Lebelhomme, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Journal of Vascular Surgery. Venous and Lymphatic Disorders|August 19, 2017
Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluationSophie Blaise, Bernadette Satger, Gilles Pernod, et al.
Thrombosis Research|March 4, 2014
Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trialPatrick Imbert, Gilles Pernod, Jean-Pierre Jacquet, et al.
Family Practice|October 24, 2024
Patients treated with vitamin K oral anticoagulants in family practice: a new approach to bleeding risk assessment. An ancillary study by the CACAO prospective general practice cohortYoann Gaboreau, Paul Frappé, Celine Vermorel, et al.
Journal of Thrombosis and Thrombolysis|April 25, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism: commentYoann Gaboreau, Nora Zenatti, Céline Vermorel, et al.
Family Practice|January 28, 2024
Oral anticoagulant safety in family practice: prognostic accuracy of Bleeding Risk Scores (from the CACAO study)Yoann Gaboreau, Paul Frappé, Céline Vermorel, et al.
Thrombosis Research|January 23, 2017
Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohortNora Zenati, Yoann Gaboreau, Cynthia Brousseau Provencher, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 31, 2004
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four casesPatricia Pavese, Agnès Bonadona, Jean Beaubien, et al.
Thrombosis and Haemostasis|April 8, 2006
Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Description of 62 novel mutationsChristine Vinciguerra, Christophe Zawadzki, Yesim Dargaud, et al.
European Journal of Radiology|April 21, 2010
Non-severe pulmonary embolism: prognostic CT findingsAnne-Line Moroni, Jean-Luc Bosson, Noélie Hohn, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|September 24, 2015
[Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management]Claire Soave, Elena Chidlovskii, Audrey Lebelhomme, et al.
Pageof 10